Outcomes and Barriers Associated with Telehealth-Based Hepatitis C Treatment During Early Phases of the COVID-19 Pandemic

By sjmartinez • June 5, 2024

Chen PH, Truong J, Kawamoto J, Bhattacharya D, Patel A. Outcomes and Barriers Associated with Telehealth-Based Hepatitis C Treatment During Early Phases of the COVID-19 Pandemic. Fed Pract. 2024 Mar;41(3):88-92. doi: 10.12788/fp.0460. Epub 2024 Mar 15. PMID: 38835674; PMCID: PMC11147438.

Tags: Digestive Diseases, Fellow, Infectious Diseases, Publications, Veterans Administration

Early-life obesogenic environment integrates immunometabolic and epigenetic signatures governing neuroinflammation

Ontiveros-Ángel P, Vega-Torres JD, Simon TB, Williams V, Inostroza-Nives Y, Alvarado-Crespo N, Gonzalez YV, Pompolius M, Katzka W, Lou J, Sharafeddin F, De la Peña[...]

Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis

Ananthakrishnan AN, Murad MH, Scott FI, Agrawal M, Haydek JP, Limketkai BN, Loftus EV Jr, Singh S. Comparative Efficacy of Advanced Therapies for Management of[...]

Quality measures in the delivery of equitable endoscopic care to traditionally underserved patients in the United States

ASGE Quality Assurance in Endoscopy Committee; Williams KN, May FP, Cummings LC, Srivastava N, Shahidi N, Kohansal A, Panganamamula K, Garg R, Singh A, Green[...]